Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ASPET celebrates its centennial anniversary: 1911-1920

Dayle Houston

    Molecular Interventions
    |July 5, 2007
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ASPET celebrates its centennial anniversary. 1981-1990.

    Molecular interventions·2008
    Same author

    1971-1980.

    Molecular interventions·2008
    Same author

    Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor.

    Combinatorial chemistry & high throughput screening·2008
    Same author

    1921-1930.

    Molecular interventions·2007
    Same author

    P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoring.

    Journal of medicinal chemistry·2007
    Same author

    [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors.

    British journal of pharmacology·2005
    Same journal

    Spindle poisons and cell fate: a tale of two pathways.

    Molecular interventions·2011
    Same journal

    CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.

    Molecular interventions·2011
    Same journal

    Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states.

    Molecular interventions·2011
    Same journal

    New therapeutic approaches to combat arterial thrombosis: better drugs for old targets, novel targets, and future prospects.

    Molecular interventions·2011
    Same journal

    The secrets of a successful clinical trial: compliance, compliance, and compliance.

    Molecular interventions·2011
    Same journal

    Asthma therapeutics: recent strides, new hurdles.

    Molecular interventions·2011
    See all related articles